October 5: Accountability in CRO Relationships
Learn about building accountability into CRO relationships at the outset
Webinars
Resources
Webinars
Corporate News
Fact Sheets
Danforth Clinical Finance
Learn more about our Clinical Finance services
Corporate News
Danforth Advisors Promotes Chris Connors to Chief Executive Officer
Leadership team news
Insights
The Business Section of Your Form S-1 is the Tip of the Spear
The quality of your business section largely dictates the pace of your filing
Case Studies
Oncologie
We established the finance function, led financing strategy and handled technical accounting for audit readiness
Fact Sheets
Danforth Accounting and Reporting Advisory
Learn more about our technical accounting capabilities
Fact Sheets
Danforth Form S-1 Drafting Services
Learn more about our Form S-1 business section drafting expertise
Press
Podcast Interview: Biotech’s IPO Steamroll
Gregg Beloff discusses the drivers behind the biotech boom of 2020
Insights
Demystifying SPACs
SPACs are a hot topic. Learn about this non-traditional path to going public.
Case Studies
Apellis Pharmaceuticals
We provided strategic CFO leadership and operational support to pave the path for growth
Webinars
Finding Capital and Controlling Your Agreements
A webinar on the all-important subject of finding capital, including private offerings, IPOs and SPACs
Fact Sheets
Danforth Strategic and Operational Human Resources
Learn more about our new Strategic and Operational HR capabilities
Webinars
Streamline the Business Side of Clinical Outsourcing
Maximize performance and mitigate risk of outsourced clinical programs
Corporate News
Danforth Advisors Appoints Bettina Davids as Chief Financial Officer
Leadership team news
Press
Q&A with John Hallinan, Chief Development Officer
A conversation about the evolving formation model and needs of life science start-ups
Corporate News
John Hallinan Joins Danforth Advisors as First Chief Development Officer
Leadership team news
Case Studies
EyePoint Pharmaceuticals
We partnered with the CEO to enable a corporate transformation from R&D to commercial ready